The difficulty in timing for liver transplantation in cirrhotic patients coinfected with HIV: In search for a prognosis score

Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus

“…Following our experience with the first 7 patients,9 and in light of the fact that of the 9 patients who underwent transplantation between December 1999 and February 2003, 7 died and 3 were treated with DDI and/or d4T, whereas 1 died because of mitochondrial toxicity and a recurrence of HCV, we decided to avoid using nucleosides such as DDI and d4T analogs after LT and subsequently did not observe any lethal complications of HAART therapy during the post‐LT period. The avoidance of such complications, together with the transplantation of patients with lower MELD scores, will probably improve the survival of HCV‐HIV–coinfected patients 22–25…”

Impact of Human Immunodeficiency Virus on Survival After Liver Transplantation: Analysis of United Network for Organ Sharing Database

“…HIV/HBV-coinfected LT recipients seem to have better outcomes compared with those in HIV/HCV-coinfected liver transplant recipients as long as they receive early referral for LT and treatment of lamivudine-resistant HBV infection after LT (24,25).…”